Atlas FDA

Surpass Streamline Flow Diverter

FDA premarket approval P170024/S010 · decided 2022-08-05

Approval details

PMA number
P170024
Supplement
S010
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Trade name
Surpass Streamline Flow Diverter
Generic name
Intracranial aneurysm flow diverter
Applicant
Stryker Neurovascular
Date received
2021-10-18
Decision date
2022-08-05
Days to decision
291 days
Decision code
APPR
Product code
OUT
Advisory committee
Neurology
Expedited review
No
Location
Fremont, CA
Statement
Approval for labeling changes to incorporate completed results from the post-approval study (PAS) titled Surpass Intracranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms (SCENT).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Trevo Trak 21 Microcatheter (K261889)Stryker Neurovascular2026-07-01
AXS Lift Intracranial Base Catheter (K253032)Stryker Neurovascular2026-02-11
Target Detachable Coil (K252694)Stryker Neurovascular2025-12-11
InZone IST Detachment System; IZDS Connecting Cable (K251832)Stryker Neurovascular2025-10-17
Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27 Pre-Shaped Microcatheter, Excelsior XT-27 Flex Pre-Shaped Microcatheter (K242289)Stryker Neurovascular2025-03-21
AXS Lift Intracranial Base Catheter (K243593)Stryker Neurovascular2025-02-18
Broadway 8 Catheter (K241768)Stryker Neurovascular2024-12-19
Echo Intracranial Base Catheter (K241637)Stryker Neurovascular2024-12-19